Goldman Sachs' Salveen Richter on Sarepta's ongoing troubles, opportunities in biotech

Молочные продукты после 40–50 лет, есть или исключить? Что укрепляет кости, а что их разрушает.

Moderna Co-Founder and Flagship Pioneering CEO on the Future of Biotech | WSJ News

The story of Sarepta's Duchenne gene therapy

Sarepta Therapeutics: Safety Update on ELEVIDYS in Non-Ambulatory Individuals Living with Duchenne

Everything They Teach You at Goldman Sachs in 36 Minutes

Will the Dollar Keep Dropping?

Former FDA commissioner Dr. Scott Gottlieb on the future of gene therapy

HC Wainwright's Kapoor talks if Sarepta shares could hit $0

LYFT, SPRT, RELY: Three Live Stock Pitches from Strivepoint Capital

Market expectations for 2026 look pretty promising, says Morgan Stanley's Chris Toomey

Почему Ты Просыпаешься В 3–4 Ночи? 5 Причин, О Которых Молчат Врачи.....

AI & future of workforce: Andrew Yang on how the technology will impact jobs

BMO's Kostas Biliouris: It will be challenging for the FDA to force a market withdrawal for Sarepta

3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore

Viking Therapeutics soars then drops on obesity data

ДЕНЬГИ ВЫВОЗЯТ ВАГОНАМИ. Зачем ЦБ открыл границы для оттока капитала? | Валентин Катасонов

Mizuho's Jared Holz on what is next for Sarepta after second death connected to gene therapy

К чему готовится Лукашенко? | «Новости» с Чалым

Владимир Милов: "Заткните своего мальчика". Ссора Кара-Мурзы и Каспарова

It is time for a move higher in biotech, says Mizuho's Jared Holz